Applied Sciences (Apr 2021)

Orally Administered Activated Charcoal as a Medical Countermeasure for Acute Radiation Syndrome in Rats

  • Elisaveta Snezhkova,
  • Natalia Rodionova,
  • Dennis Bilko,
  • Joaquin Silvestre-Albero,
  • Alexey Sydorenko,
  • Olga Yurchenko,
  • Marharyta Pakharenko,
  • Mo Alavijeh,
  • Kvitoslava Bardakhivska,
  • Natalia Riabchenko,
  • Vladimir Nikolaev

DOI
https://doi.org/10.3390/app11073174
Journal volume & issue
Vol. 11, no. 7
p. 3174

Abstract

Read online

Activated charcoal (AC) can be taken orally as enterosorbent for treatment of pathological states related to exogenous and endogenous intoxications. Synthesized granulated AC with a highly developed active surface (SBET ~2700 m2/g) was used as a medical countermeasure (MCM) to acute radiation sickness (ARS) in rats after total body X-ray irradiation. AC demonstrates positive results in ARS treatment, as expressed in, (i) a decrease in body weight loss, (ii) a protection of bone marrow (BM) cells colony formation capacity, (iii) a reduction of BM chromosomal aberrations and small intestine and spleen tissue damage, (iv) an amelioration of white blood cell count, and (v) a mitigation of superoxide ion generation rate in the liver. AC oral prescription seems to be perspective modality of ARS treatment.

Keywords